Author details

Full Name

Giusy Della Gatta

Affiliation

ORCID

Career Start Year

1994

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37328064	In-Depth Mass Spectrometry Analysis Reveals the Plasma Proteomic and N-Glycoproteomic Impact of an Amish-Enriched Cardioprotective Variant in B4GALT1.	Mol Cell Proteomics	2023
37800623	Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.		2023
35939579	Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease.	N Engl J Med	2022
35999217	Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.	Nat Commun	2022
34645820	Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance.	Nat Commun	2021
34210852	Sequencing of 640,000 exomes identifies <i>GPR75</i> variants associated with protection from obesity.	Science	2021
33043467	Butyrate as a bioactive human milk protective component against food allergy.	Allergy: European Journal of Allergy and Clinical Immunology	2021
34855475	Genetic and functional evidence links a missense variant in <i>B4GALT1</i> to lower LDL and fibrinogen.	Science	2021
32924017	Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemia.	Blood Cancer Discov	2020
31797399	The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12 in infant colic: A randomised, double blind, placebo-controlled trial.	Alimentary Pharmacology and Therapeutics	2020
31943267	Editorial: interventions in infantile colic - can efficacy be attributed to treatment or to time? Authors' reply.	Alimentary Pharmacology and Therapeutics	2020
30828329	Gut Microbiome as Target for Innovative Strategies Against Food Allergy.	Frontiers in Immunology	2019
30680644	Targeting Food Allergy with Probiotics.	Advances in Experimental Medicine and Biology	2019
31327562	Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow's Milk Allergy.	Journal of Pediatrics	2019
30131575	Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy.	Sci Rep	2018
22366949	Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.	Nat Med	2012
22162831	ETV6 mutations in early immature human T cell leukemias.	Journal of Experimental Medicine	2011
20081848	Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex.	Nature Immunology	2010
20972433	The TLX1 oncogene drives aneuploidy in T cell transformation.	Nat Med	2010
19259117	Systems and Synthetic biology: tackling genetic networks and complex diseases.	Heredity	2009
18441228	Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineering.	Genome Research	2008
18256694	Tprg, a gene predominantly expressed in skin, is a direct target of the transcription factor p63.	J Invest Dermatol	2008
16618808	Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation.	Genes and Development	2006
16418235	Inference of gene regulatory networks and compound mode of action from time course gene expression profiles.	Bioinformatics	2006
17281300	Discovering drug mode of action using reverse-engineered gene networks.	Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings	2005
16141072	The transcriptional landscape of the mammalian genome.	Science	2005
7919032	Hydration enthalpy of model peptides: N-acetyl amino acid amides.	Biophysical Chemistry	1994